Sernova Biotherapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 10, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Capitalization	49	59	81	244	234	326
Market Cap Growth	-21.22%	-27.14%	-66.65%	3.99%	-28.16%	491.44%
Enterprise Value	54	64	77	213	193	297
Last Close Price	0.14	0.15	0.25	0.76	0.80	1.25
PB Ratio	-1.96	-2.36	-6.28	19.49	4.93	11.63
P/TBV Ratio	-	-	-	19.99	4.98	11.93
Debt / Equity Ratio	-0.19	-0.19	-0.04	0.01	0.01	0.01
Quick Ratio	0.02	0.02	0.32	2.17	10.74	19.19
Current Ratio	0.02	0.02	0.32	2.19	10.78	19.19
Return on Equity (ROE)	-	-	-	-129.72%	-64.54%	-43.25%
Return on Assets (ROA)	-226.48%	-226.48%	-133.56%	-67.87%	-37.59%	-24.39%
Return on Capital Employed (ROCE)	62.50%	62.50%	253.60%	-323.60%	-51.80%	-24.50%
Earnings Yield	-32.02%	-26.57%	-39.58%	-15.99%	-10.41%	-2.13%
FCF Yield	-	-18.41%	-23.23%	-12.48%	-6.29%	-2.10%
Buyback Yield / Dilution	-6.95%	-6.95%	-1.19%	-10.87%	-11.43%	-24.45%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.